Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krisztina Bencsik

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Ideggyogyaszati Szemle|December 17, 2014
[[Natalizumab therapy, 2013]Mária Karácsony, Krisztina Bencsik, László Vécsei
Ideggyogyaszati Szemle|October 6, 2015
[TERIFLUNOMIDE: A NEW ORAL IMMUNOMODULATING AGENT FOR MULTIPLE SCLEROSIS]Krisztina Bencsik, Csilla Rózsa, László Vécsei
Ideggyogyaszati Szemle|June 6, 2018
[Alemtuzumab therapy 2017]Tamás Biernacki, Krisztina Bencsik, Dániel Sandi, et al.
Mini Reviews in Medicinal Chemistry|October 24, 2019
Medicinal Chemistry of Multiple Sclerosis: Focus on CladribineTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 20, 2013
Pregnancy and perinatal outcomes among women with multiple sclerosis: a retrospective case-controlled study in South HungaryMelinda Vanya, Tibor Nyari, Krisztina Bencsik, et al.
Cells|July 2, 2020
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic PerspectivesTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important PlayersDániel Sandi, Zsanett Fricska-Nagy, Krisztina Bencsik, et al.
Journal of Neuroimmunology|April 18, 2002
Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patientsCecilia Rajda, Krisztina Bencsik, László Vécsei L, et al.
Ideggyogyaszati Szemle|May 8, 2018
Unilateral thalamic infarction causing downward gaze palsy in a patient with uncorrected tetralogy of fallot: a case reportÁdám Annus, Krisztina Bencsik, Tamás Járdánházy, et al.
European Neurology|November 25, 2003
Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatmentEszter Karg, Peter Klivenyi, Krisztina Bencsik, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Ideggyogyaszati Szemle|December 17, 2014
[[Natalizumab therapy, 2013]Mária Karácsony, Krisztina Bencsik, László Vécsei
Ideggyogyaszati Szemle|October 6, 2015
[TERIFLUNOMIDE: A NEW ORAL IMMUNOMODULATING AGENT FOR MULTIPLE SCLEROSIS]Krisztina Bencsik, Csilla Rózsa, László Vécsei
Ideggyogyaszati Szemle|June 6, 2018
[Alemtuzumab therapy 2017]Tamás Biernacki, Krisztina Bencsik, Dániel Sandi, et al.
Mini Reviews in Medicinal Chemistry|October 24, 2019
Medicinal Chemistry of Multiple Sclerosis: Focus on CladribineTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 20, 2013
Pregnancy and perinatal outcomes among women with multiple sclerosis: a retrospective case-controlled study in South HungaryMelinda Vanya, Tibor Nyari, Krisztina Bencsik, et al.
Cells|July 2, 2020
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic PerspectivesTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important PlayersDániel Sandi, Zsanett Fricska-Nagy, Krisztina Bencsik, et al.
Journal of Neuroimmunology|April 18, 2002
Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patientsCecilia Rajda, Krisztina Bencsik, László Vécsei L, et al.
Ideggyogyaszati Szemle|May 8, 2018
Unilateral thalamic infarction causing downward gaze palsy in a patient with uncorrected tetralogy of fallot: a case reportÁdám Annus, Krisztina Bencsik, Tamás Járdánházy, et al.
European Neurology|November 25, 2003
Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatmentEszter Karg, Peter Klivenyi, Krisztina Bencsik, et al.
Pageof 7